Enhancing diabetic wound healing with a pH/glucose dual-responsive hydrogel for ROS clearance and antibacterial activity.

Currently, the treatment of diabetic wounds in clinical practice is still unsatisfactory due to the risks of oxidative damage and bacterial infection during the healing process. An optimal wound dressing should exhibit robust capabilities in scavenging reactive oxygen species (ROS) and combatting bacterial growth. In this study, we utilized borax as a crosslinker and prepared a pH/glucose dual-responsive composite hydrogel based on poly(vinyl alcohol) (PVA), sodium alginate (SA), and tannic acid (TA). This hydrogel, loaded with cerium dioxide, serves as an effective ROS scavenger, promoting wound closure by reducing the level of ROS in the wound area. Additionally, the hydrogel can release the antibacterial drug ofloxacin in response to the low pH and high glucose microenvironment in infected wounds. Results from skin defect model in diabetic mice demonstrated this ROS-scavenging and antibacterial hydrogel can suppress inflammation and accelerate wound healing. In summary, our work provides a new perspective on a local and stimulus-responsive drug delivery strategy for treating diabetic wounds. Our study presents a pH/glucose-responsive Ofloxacin/CeO 2 -TA-SA-PVA/Borax hydrogel (OX-Ce-GEL) for diabetic wound healing. The hydrogel, crosslinked with borax, scavenges reactive oxygen species (ROS) and releases ofloxacin in response to low pH and high glucose levels. This dual-responsive hydrogel accelerates wound closure by reducing ROS and combating bacterial growth. In a diabetic mouse model, the hydrogel suppressed inflammation and promoted wound healing. Our work offers a localized and stimuli-responsive drug release strategy for diabetic wounds. [Display omitted] [ABSTRACT FROM AUTHOR]